FEB 18, 2021
By
Jayanth S Sridhar, MD,
Carl D Regillo, MD, FACS,
Anat Loewenstein, MD,
Nadia Khalida Waheed, MD,
Jeffrey S Heier, MD
Straight From the Cutter's Mouth
30:15
Retina/Vitreous
Drs. Carl Regillo, Nadia Waheed, Anat Loewenstein and Jeffrey Heier join to discuss their respective talks at the Angiogenesis 2021 meeting, including the port delivery system phase 3 results, gene therapy for geographic atrophy, home OCT monitoring with artificial intelligence, and faricimab phase 3 results for AMD.
Financial Disclosures: Dr. Regillo is a consultant and receives research grant funding from Genentech. Dr. Loewenstein is a consultant for Notal Vision. Dr. Waheed receives research funding from Gyroscope. Dr. Heier is a consultant and receives research grant funding from Genentech. Dr. Sridhar is a consultant for Regeneron.